Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Atsumasa Komori

Clin Mol Hepatol. 2024;30(4):1035-1036. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0242

View: 1710 Download: 41

Haeryoung Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2024;30(2):291-292. Published online March 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0180

View: 2627 Download: 48 Web of Science: 1 Crossref: 1

Soomin Ahn, Sook-Hyang Jeong, Eun Ju Cho, Kyoungbun Lee, Gilhyang Kim, Haeryoung Kim

Clin Mol Hepatol. 2024;30(1):37-48. Published online November 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0325

View: 3846 Download: 229 Web of Science: 4 Crossref: 7

Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, Regina Lo, Kihan Yap, Haeryoung Kim

Clin Mol Hepatol. 2023;29(Suppl):S302-S318. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0329

View: 7447 Download: 319 Web of Science: 28 Crossref: 27

Jeong-Ju Yoo, Sang Gyune Kim

Clin Mol Hepatol. 2023;29(2):513-515. Published online February 15, 2023

DOI: https://doi.org/10.3350/cmh.2023.0044

View: 3235 Download: 57

Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(2):305-312. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0301

View: 6213 Download: 172 Web of Science: 11 Crossref: 12

Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, Ru Bai, Junwei Cheng, Meng Yu, Alexander Liberman, Liping Liu, Nadege Gunn

Received February 8, 2025 Accepted April 17, 2025

DOI: https://doi.org/10.3350/cmh.2025.0145 [Accepted]

View: 410 Download: 31

1 |

Viewed By 10962	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7667	MAFLD: How is it different from NAFLD?
Viewed By 5558	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 5016	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 4914	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Cited By 342	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 316	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 210	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 104	Non-alcoholic fatty liver disease: Definition and subtypes

Search